Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

Míreanna comhchosúla

• Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
  de réir: Mukhtyar, C, et al.
  Foilsithe / Cruthaithe: (2006)
• EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis.
  de réir: Hellmich, B, et al.
  Foilsithe / Cruthaithe: (2007)
• Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
  de réir: Walsh, M, et al.
  Foilsithe / Cruthaithe: (2011)
• Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
  de réir: Mukhtyar, C, et al.
  Foilsithe / Cruthaithe: (2008)
• Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
  de réir: Flossmann, O, et al.
  Foilsithe / Cruthaithe: (2006)